EMA approves Bevespi Aerosphere as a new maintenance bronchodilator treatment
The European Medicines Agency's (EMA's) Committee for Medicinal Products for Human Use (CHMP) has recommended marketing for the medicinal product Bevespi Aerosphere, intended for the maintenance treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD)... read more
AF progression is associated with increased adverse events
Results of a survey of the patients with atrial fibrillation (AF) in Fushimi-ku, Kyoto published in the October 2018 issue of the journal Stroke show that AF progression was associated with increased risk of clinical adverse events -... read more
Insulin resistance is prevalent in children as young as age 6
A significant percentage of 6-year-old children showed abnormal metabolic profiles, including insulin resistance, which increased their risk of cardiovascular disease in a longitudinal cohort study of healthy children, the results of which .. read more
Shorter duration of sleep apnea increases mortality risk
Duration of the apnea-hypopnea event is a predictor of mortality in obstructive sleep apnea (OSA). According to the study published online October 19, 2018 in the American Journal of Respiratory and Critical Care Medicine, individuals with shorter respiratory events may be predisposed to increased ventilatory instability... read more
Better cardiorespiratory fitness leads to longer life
A retrospective study of 122,007 patients who underwent exercise treadmill testing at Cleveland Clinic between Jan. 1, 1991, and Dec. 31, 2014, to measure all-cause mortality relating to the benefits of exercise and fitness found that increased cardiorespiratory fitness was directly associated with reduced long-... read more